296 related articles for article (PubMed ID: 26362843)
1. Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study.
Corominas H; Narváez J; Díaz-Torné C; Salvador G; Gomez-Caballero ME; de la Fuente D; Campoy E; Roig-Vilaseca D; Clavaguera T; Morlà R; Torrente-Segarra V; Arasa X; Gomez-Puerta JA; Möller I; Alegre C; Graell E; Ponce A; Lisbona MP; Pérez-Garcia C; Fíguls R; Sirvent E; Poca V; Sanmartí R
Reumatol Clin; 2016; 12(3):146-50. PubMed ID: 26362843
[TBL] [Abstract][Full Text] [Related]
2. Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.
Nanji JA; Choi M; Ferrari R; Lyddell C; Russell AS
J Rheumatol; 2012 Apr; 39(4):707-11. PubMed ID: 22337235
[TBL] [Abstract][Full Text] [Related]
3. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.
Hernández-García C; Vargas E; Abásolo L; Lajas C; Bellajdell B; Morado IC; Macarrón P; Pato E; Fernández-Gutiérrez B; Bañares A; Jover JA
J Rheumatol; 2000 Oct; 27(10):2323-8. PubMed ID: 11036824
[TBL] [Abstract][Full Text] [Related]
4. Long-term impact of delay in assessment of patients with early arthritis.
van der Linden MP; le Cessie S; Raza K; van der Woude D; Knevel R; Huizinga TW; van der Helm-van Mil AH
Arthritis Rheum; 2010 Dec; 62(12):3537-46. PubMed ID: 20722031
[TBL] [Abstract][Full Text] [Related]
5. Achievement of NICE quality standards for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.
Ledingham JM; Snowden N; Rivett A; Galloway J; Ide Z; Firth J; MacPhie E; Kandala N; Dennison EM; Rowe I
Rheumatology (Oxford); 2017 Feb; 56(2):223-230. PubMed ID: 27694337
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid arthritis referrals and rheumatologist scarcity: a prioritization tool.
Cummins LL; Vangaveti V; Roberts LJ
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):326-31. PubMed ID: 25156328
[TBL] [Abstract][Full Text] [Related]
7. A detailed analysis of treatment delay from the onset of symptoms in early rheumatoid arthritis patients.
De Cock D; Meyfroidt S; Joly J; Van der Elst K; Westhovens R; Verschueren P;
Scand J Rheumatol; 2014; 43(1):1-8. PubMed ID: 24050519
[TBL] [Abstract][Full Text] [Related]
8. Delayed diagnosis and treatment of rheumatoid arthritis in Sarawak General Hospital.
Wan SA; Teh CL; Cheong YK; Jobli AT
Med J Malaysia; 2020 Mar; 75(2):141-145. PubMed ID: 32281595
[TBL] [Abstract][Full Text] [Related]
9. Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city.
Jamal S; Alibhai SM; Badley EM; Bombardier C
J Rheumatol; 2011 Jul; 38(7):1282-8. PubMed ID: 21572157
[TBL] [Abstract][Full Text] [Related]
10. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.
Aletaha D; Eberl G; Nell VP; Machold KP; Smolen JS
Ann Rheum Dis; 2002 Jul; 61(7):630-4. PubMed ID: 12079906
[TBL] [Abstract][Full Text] [Related]
11. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).
Westhoff G; Schneider M; Raspe H; Zeidler H; Runge C; Volmer T; Zink A
Rheumatology (Oxford); 2009 Jun; 48(6):650-7. PubMed ID: 19321515
[TBL] [Abstract][Full Text] [Related]
12. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.
Emery P; Breedveld FC; Dougados M; Kalden JR; Schiff MH; Smolen JS
Ann Rheum Dis; 2002 Apr; 61(4):290-7. PubMed ID: 11874828
[TBL] [Abstract][Full Text] [Related]
13. Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice.
Irvine S; Munro R; Porter D
Ann Rheum Dis; 1999 Aug; 58(8):510-3. PubMed ID: 10419871
[TBL] [Abstract][Full Text] [Related]
14. [Descriptive study of the use of DMARD in patients with rheumatoid arthritis or persistent arthritis who start drug treatment in Spain (FIRST)].
Blanco FJ; Ballina J; Carbonell J; Martín-Mola E; Tornero J; Ramírez E; Galván J
Reumatol Clin; 2011; 7(2):88-93. PubMed ID: 21794790
[TBL] [Abstract][Full Text] [Related]
15. Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis.
Rodríguez-Polanco E; Al Snih S; Kuo YF; Millán A; Rodríguez MA
Rheumatol Int; 2011 May; 31(5):657-65. PubMed ID: 20066425
[TBL] [Abstract][Full Text] [Related]
16. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide.
Massardo L; Suárez-Almazor ME; Cardiel MH; Nava A; Levy RA; Laurindo I; Soriano ER; Acevedo-Vázquez E; Millán A; Pineda-Villaseñor C; Galarza-Maldonado C; Caballero-Uribe CV; Espinosa-Morales R; Pons-Estel BA
J Clin Rheumatol; 2009 Jun; 15(4):203-10. PubMed ID: 19502907
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.
Bonafede MM; Fox KM; Johnson BH; Watson C; Gandra SR
Clin Ther; 2012 Feb; 34(2):457-67. PubMed ID: 22284901
[TBL] [Abstract][Full Text] [Related]
18. Relationships between driving distance, rheumatoid arthritis diagnosis, and disease-modifying antirheumatic drug receipt.
Polinski JM; Brookhart MA; Ayanian JZ; Katz JN; Kim SC; Lii J; Tonner C; Yelin E; Solomon DH
Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1634-43. PubMed ID: 24664991
[TBL] [Abstract][Full Text] [Related]
19. Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population.
Shipton D; Glazier RH; Guan J; Badley EM
Med Care; 2004 Sep; 42(9):907-13. PubMed ID: 15319617
[TBL] [Abstract][Full Text] [Related]
20. 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.
Sanmartí R; García-Rodríguez S; Álvaro-Gracia JM; Andreu JL; Balsa A; Cáliz R; Fernández-Nebro A; Ferraz-Amaro I; Gómez-Reino JJ; González-Álvaro I; Martín-Mola E; Martínez-Taboada VM; Ortiz AM; Tornero J; Marsal S; Moreno-Muelas JV
Reumatol Clin; 2015; 11(5):279-94. PubMed ID: 26051464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
